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INTRODUCTION:  Prostatic  stromal  sarcomas  account  for about  0.1%  of  all prostatic  malignancies.  Local
recurrence  into  bladder,  seminal  vesicles  and  rectum  has  been  documented.  Distal  metastasis,  has  so  far
only  been  reported  in lung  and  bone.
PRESENTATION  OF  CASE:  We  report  the  case  of  a 42  year  old  man  with  a subcutaneous  metastatic  deposit
of a prostatic  stromal  cell  sarcoma  5 years  after  radical  prostatectomy.  Additional  staging  with  CT-  and
PET-scan  showed  lymph  node  involvement  in  the neck  and  left axilla.  A  core  biopsy  of  the  skin  lesion  was
undertaken,  of which  the  histology  revealed  a low  grade  spindle  cell tumour  that  was  morphologically
identical  to a  previously  diagnosed  prostatic  stromal  sarcoma.rostate
tromal tumours of uncertain malignant
otential (STUMP)
kin
etastasis
DISCUSSION:  In literature  distant  metastases  to the  lung  and bone  have  been  documented  before.  This  is
the  ﬁrst  documented  case  of  a subcutaneous  metastasis  of prostatic  stromal  cell sarcoma.
CONCLUSION:  The  preferred  treatment  for prostatic  stromal  cell  sarcoma  is surgery  by  radical  prostate-
ctomy  or cystoprostatectomy.  There is  currently  not  enough  literature  on  the  topic  to elucidate  the  role
of chemo-  or  radiotherapy  in  loco-regional  or distant  spread.
©  2015  The  Authors.  Published  by  Elsevier  Ltd.  on behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
he CCaccess  article  under  t
. Case report
A 42 year old man  was referred to the Emergency Department by
he General Practitioner (GP) under the suspicion of a large infected
ebaceous cyst (Fig. 1). The GP had tried a needle aspiration twice
ithout any lasting success. On history the patient had noticed the
esion about a year ago and it had steadily increased in size only
ausing pain and discomfort for the last month. On examination
 5 × 7 cm irregular lesion was seen above the left shoulder blade.
nly the overlying skin was erythematous with no further signs
f inﬂammation. The consistency felt solid/rubbery without clear
uctuance and it appeared to be mobile.
A soft tissue mass was concluded and a staging CT-
houlder–chest–abdomen MRI  shoulder and a PET-scan were
rdered. The CT and MRI  revealed the subcutaneous mass of the left
houlder overlying and indenting the trapezius muscle, but with-
ut clear involvement (Fig. 2). No other localisations were seen.
he PET scan, in addition to the mass in the shoulder, showed some
vid lymph nodes in the neck and left axilla, in keeping with nodal
etastasis. A core biopsy of the skin lesion was undertaken, of
hich the histology revealed a low grade spindle cell tumour that
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was morphologically identical to a previously diagnosed prostatic
stromal sarcoma. Morphological features included a highly cellular
tumour that contains relatively bland spindle cells arranged in rel-
atively short intersecting fascicles with abrupt areas of high mitotic
activity. The tumour stained positive for vimentin, a mesenchymal
marker, and negative for epithelial markers such as cytokeratin.
It is this very close morphological similarity to the original pro-
static sarcoma that makes this tumour deposit very likely to be a
metastasis rather than a new one.
In 2009 the patient had undergone a radical prostatectomy and
pelvic lymph node dissection for a prostate malignancy. The histol-
ogy then showed a low grade prostatic stromal cell sarcoma arising
within a prostatic stromal tumour of uncertain malignant poten-
tial conﬁned to the prostate gland. All resection margins were clear.
Earlier this year, the patient had a colonoscopy for rectal bleeding
and a small polyp was removed from the rectum. This was initially
reported as a solitary ﬁbrous tumour with an area of spindle cell
proliferation. However after comparison to the previous prostate
tissue and the current skin lesion it was reviewed and considered
metastatic prostate sarcoma as well. Otherwise the patient’s past
medical history was unremarkable.
In conclusion the patient presented with a large metastatic sub-
cutaneous deposit of a prostate stromal sarcoma with lymph node
metastasis in axilla and neck and a local recurrence within the
rectum.
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iFig. 1. Irregular 5 × 7 cm mass on back of left shoulder/trapezius area.
. Discussion
Stromal cell tumours of the prostate were ﬁrst described in 1998
y Gaudin et al. who broadly classiﬁed them as either prostatic stro-
al  tumours of uncertain malignant potential (STUMP) or prostatic
tromal sarcomas (PSS) [1]. The distinction depended on histologi-
al features of stromal overgrowth, variable cellular atypia, mitosis,
nd increased cellularity [1,2]. There is however no conclusive data
hat prove that these two entities belong to a spectrum of the same
isease entity.
Prostatic stromal sarcomas account for about 0.1% of all pro-
tatic malignancies [3,4]. They usually present symptomatically as
aematuria, haematospermia, urinary retention and as a palpable
ectal mass [2,3,5,6]. A wide age distribution from 26 to 85 years
as been reported [3].
ig. 2. Axial slice of CT chest showing stromal cell sarcoma overlying the left trapez-
us muscle (arrow).PEN  ACCESS
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Macroscopically prostatic stromal sarcomas can have solid areas
mixed in with cystic components [5]. They vary in size and can
have areas of oedema, haemorrhage or necrosis. Microscopically,
PSS display a growth of spindle cells in the stroma of the prostate;
either alone or mixed in with benign glandular tissue [5]. These
neoplastic spindle cells show cytological atypia, mitotic ﬁgures,
and necrosis [2,5,6]. The solid component of the tumour can show
various patterns of cell arrangement such as storiform, epithelioid,
ﬁbrosarcomatous, or patternless patterns [5,6]. Depending on the
amount of histological features that are present these tumors can
be further classiﬁed into high or low grade malignancies [2,6].
The preferred treatment is surgery by radical prostatectomy or
cystoprostatectomy [7–9]. There is currently not enough literature
on the topic to elucidate the role of chemo- or radiotherapy.
Given the rarity of the disease long term outcomes have only
been reported in small series or case reports. Local recurrence
occurs in to bladder, seminal vesicles and rectum [7–9]. Distal
metastasis, have so far only been reported in lung and bone [7,9].
This is also two  of the most common sites of distal metastasis for
prostate adenocarcinoma [10]. In this case report we  present the
ﬁrst case of a subcutaneous metastasis of a prostatic stromal cell
sarcoma to the back of the shoulder. As far as we are aware this has
not been presented before.
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